China's blood pressure monitor market has great growth prospects due to increasing health management demand in small cities and counties, and Omron Healthcare China Co Ltd will continue its localized strategies to further tap the potentials of Chinese market, according to its senior executives.

In smaller cities and county-level markets, the company will introduce modified products with lower prices to meet specific demand for products, not simply selling products that have succeeded in markets of first-tier cities, said Okawa Rikiya, executive vice-president.

It will also enrich its product portfolios in China, to further strengthen its image as a mature and reliable provider of home-use health management devices, he said, adding cooperation with e-commerce platforms was also important, because China leads the world in online shopping.

About 70 percent of Omron China's revenues are from blood pressure monitors, yet the company has also been enjoying fast growth in areas such as devices for respiratory disease and massage products, and about 40 percent of the company's sales are from e-shopping channels, Rikiya, who is also president of the company's sales department, said.

Zhao Yao, president of the company, said the company will continue to optimize its products and service through innovations in both hardware and software.

For example, he said, the company will further make use of internet technologies to upgrade capabilities of its products, such as to optimize functions such as health data tracking, uploading and analysis, so as to meet more health data management needs from both patients and doctors.